97 related articles for article (PubMed ID: 24798154)
1. Transformation of endometrioid carcinoma to carcinoma with trophoblastic differentiation: clinicopathological and whole genomic study.
Ashton KA; Scurry J; Ouveysi A; Ebbs J; Jaaback K; Bowden NA
Pathology; 2014 Jun; 46(4):351-3. PubMed ID: 24798154
[No Abstract] [Full Text] [Related]
2. Evolution of a trophoblastic tumor from an endometrioid carcinoma--a morphological and molecular analysis.
Olson MT; Gocke CD; Giuntoli RL; Shih IeM
Int J Gynecol Pathol; 2011 Mar; 30(2):117-20. PubMed ID: 21293290
[TBL] [Abstract][Full Text] [Related]
3. Malignant tumours of the uterus and ovaries with Mullerian and germ cell or trophoblastic components have a somatic origin and are characterised by genomic instability
Acosta AM; Sholl LM; Cin PD; Howitt BE; Otis CN; Nucci MR
Histopathology; 2020 Nov; 77(5):788-797. PubMed ID: 32558949
[TBL] [Abstract][Full Text] [Related]
4. Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas.
Coenegrachts L; Garcia-Dios DA; Depreeuw J; Santacana M; Gatius S; Zikan M; Moerman P; Verbist L; Lambrechts D; Matias-Guiu X; Amant F
Virchows Arch; 2015 Apr; 466(4):415-22. PubMed ID: 25677978
[TBL] [Abstract][Full Text] [Related]
5. Endometrial Adenocarcinomas With Significant Mucinous Differentiation: A Characterization of Intratumoral Heterogeneity of KRAS Mutations in Mucinous and Endometrioid Histologic Components.
Jackson CL; Hang S; Hansen K; He M; Sung CJ; Quddus MR; Xiong M; Wang Y; Patel NR; Lawrence WD; Xiong J
Int J Gynecol Cancer; 2018 Feb; 28(2):241-247. PubMed ID: 29303928
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in the pathology and epigenetics of endometrial carcinoma.
Arafa M; Somja J; Dehan P; Kridelka F; Goffin F; Boniver J; Delvenne P
Pathology; 2010 Dec; 42(7):613-7. PubMed ID: 21080868
[TBL] [Abstract][Full Text] [Related]
7. Molecular Profiles of Mixed Endometrial Carcinoma.
Matrai C; Motanagh S; Mirabelli S; Ma L; He B; Chapman-Davis E; Kurtis B; Elemento O; Mosquera JM; Ellenson LH
Am J Surg Pathol; 2020 Aug; 44(8):1104-1111. PubMed ID: 32604171
[TBL] [Abstract][Full Text] [Related]
8. Extensive trophoblastic differentiation in case of an endometrial carcinoma.
Yadav S; Sagar N; Mallya V; Mandal S; Khurana N; Gupta S
Indian J Pathol Microbiol; 2018; 61(4):614-616. PubMed ID: 30303166
[TBL] [Abstract][Full Text] [Related]
9. Mixed serous carcinoma of the endometrium with trophoblastic differentiation: analysis of the p53 tumor suppressor gene suggests stem cell origin.
Horn LC; Hänel C; Bartholdt E; Dietel J
Ann Diagn Pathol; 2008 Feb; 12(1):1-3. PubMed ID: 18164407
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
[TBL] [Abstract][Full Text] [Related]
11. Dedifferentiated endometrioid adenocarcinoma with trophoblastic components and elevated serum alfa-fetoprotein: A case report and literature review.
Cai H; Zhou R; Liang W; Wang J
Medicine (Baltimore); 2018 Apr; 97(17):e0551. PubMed ID: 29703038
[TBL] [Abstract][Full Text] [Related]
12. Endometrial carcinoma.
Di Cristofano A; Ellenson LH
Annu Rev Pathol; 2007; 2():57-85. PubMed ID: 18039093
[TBL] [Abstract][Full Text] [Related]
13. CTNNB1 -mutated High-grade Endometrioid Carcinoma With Extensive Squamous and Shadow Cell Differentiation Can Mimic Pilomatrix Carcinoma.
Mendoza R; Kertowidjojo E
Int J Gynecol Pathol; 2023 May; 42(3):325-326. PubMed ID: 35639408
[No Abstract] [Full Text] [Related]
14. POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.
Meng B; Hoang LN; McIntyre JB; Duggan MA; Nelson GS; Lee CH; Köbel M
Gynecol Oncol; 2014 Jul; 134(1):15-9. PubMed ID: 24844595
[TBL] [Abstract][Full Text] [Related]
15. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
Lax SF; Kurman RJ
Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
[TBL] [Abstract][Full Text] [Related]
16. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma.
Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343
[TBL] [Abstract][Full Text] [Related]
17. Identifying aggressive forms of endometrioid-type endometrial cancer: new insights into molecular subtyping.
Liu Y; Broaddus RR; Zhang W
Expert Rev Anticancer Ther; 2015 Jan; 15(1):1-3. PubMed ID: 25494844
[TBL] [Abstract][Full Text] [Related]
18. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA
Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218
[TBL] [Abstract][Full Text] [Related]
19. [Endometrial carcinoma and precursor lesions].
Djordjević B; Stanojević Z
Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
[TBL] [Abstract][Full Text] [Related]
20. Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.
Montserrat N; Mozos A; Llobet D; Dolcet X; Pons C; de Herreros AG; Matias-Guiu X; Prat J
Hum Pathol; 2012 May; 43(5):632-43. PubMed ID: 21940036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
